THE REGISTER

Tuesday, June 02, 2026 · ECHO HARBOR NEWS · Jun 2, 8:43 AM UTC

six in Dnipro and four in the capital Kyiv BBC News

Russian missiles and drones kill ten civilians in Kyiv and Dnipro overnight.

Four outlets agreed on the death toll. The hours before the strikes, and the state of the buildings after, appeared in none of them.

Before dawn on Monday, Russian missiles and drones struck Kyiv and Dnipro, Ukraine, killing at least ten people — "six in Dnipro and four in the capital Kyiv" (BBC News) — in what four outlets described as one of Moscow's largest assaults in recent months. Rescue operations were underway in both cities by morning. The condition of damaged buildings and the hours before the attack appeared in none of the accounts.

Today's stories

More from today's coverage, told in the same calm voice.

  1. Russia Strikes Ukrainian Cities, Killing at Least Ten

    Russian forces launched one of their largest combined missile and drone attacks in recent months, hitting Kyiv, Dnipro, and Kharkiv. At least ten civilians were killed — six in Dnipro and four in Kyiv — with dozens more wounded, including children. Buildings were damaged and residents trapped in the rubble.

    "One of Moscow's largest assaults in recent months left civilians killed and wounded across multiple Ukrainian cities."

  2. DOJ says it will stop work on $1.8 billion "anti-weaponization fund"

    The Department will abide by the Court's ruling.

  3. AI giant Anthropic says it plans to list on US stock market

    The 2026 window either becomes the most consequential IPO cycle since the dot-com era or the most expensive lesson in narrative-versus-fundamentals that public markets have ever taught.

  4. Iran Suspends Nuclear Talks After Lebanon Strikes

    Iran has suspended negotiations with the United States following Israeli military strikes in Lebanon, according to Iranian state media. The talks, which had been aimed at limiting Iran's nuclear programme in exchange for sanctions relief, now face an uncertain future. A breakdown could raise tensions around the Strait of Hormuz, through which a significant share of global oil shipments pass.

    "Tehran cited the Israeli attacks in Lebanon as the reason for halting discussions with Washington."

  5. Democrat backs flawed candidate over Trump threat

    Sunny Hostin, co-host of The View, said she would support Maine Democratic Senate candidate Graham Platner despite describing him as a liar, racist, antisemite, and homophobe. Her reasoning was that defeating Republican power in Washington outweighs concerns about Platner's character. The statement drew attention for its candid acknowledgment that the party is weighing electability against personal conduct in the 2026 race.

    "He has all the things and character does matter — but we have someone that has almost unbridled power in the White House at this point."

  6. Trump Endorsements Shape Six-State Republican Primaries

    President Trump issued endorsements ahead of Republican primary contests across six states, influencing races for governor, Congress, and Senate. Candidates backed by Trump gain significant fundraising and visibility advantages in competitive primaries. The endorsements reflect Trump's continued grip on the Republican nomination process heading into the 2026 midterm cycle.

  7. Denmark's Mette Frederiksen to form government after months of negotiations

    The deal gives her a third term as prime minister at a time when US President Donald Trump has said he wants to take over Greenland, a semi-autonomous part of Denmark.

  8. 'Beleaguered and bereft'

    Lord Mandelson says: 'They don't work as a team, they are not led and none of them really know what Keir thinks or wants. In fact most of them don't think Keir knows what he wants'.

  9. Experimental drug extends pancreatic cancer survival in trial

    A clinical trial of daraxonrasib, developed by Revolution Medicines, found that patients with previously treated metastatic pancreatic cancer lived a median of 13.2 months on the drug, compared with 6.7 months for those receiving standard chemotherapy. The results apply to patients whose tumours carry a specific KRAS mutation. The drug has not yet received FDA approval, meaning broader access depends on the regulatory process moving forward.

    "Those taking daraxonrasib lived for a median of 13.2 months compared with 6.7 months for chemotherapy recipients."

  10. South Carolina store owner acquitted in teen's shooting death

    A South Carolina jury acquitted Chikei Rick Chow of murder in the 2023 shooting death of Cyrus Carmack-Belton, a 14-year-old Black teenager, in Columbia. Prosecutors argued Chow pursued the boy and shot him in the back after a shoplifting incident. The acquittal leaves the Carmack-Belton family without a criminal conviction and has drawn grief from the local Black community.

    "Chow chased a kid down and shot him in the back."

Contact Us FAQ